- Home
- WHWK vs IGI Comparison
WHWK vs IGI Comparison
Compare WHWK & IGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- IGI
- Stock Information
- Founded
- WHWK 2007
- IGI 2009
- Country
- WHWK United States
- IGI United States
- Employees
- WHWK N/A
- IGI N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- IGI Investment Managers
- Sector
- WHWK Health Care
- IGI Finance
- Exchange
- WHWK Nasdaq
- IGI Nasdaq
- Market Cap
- WHWK 87.6M
- IGI 98.2M
- IPO Year
- WHWK N/A
- IGI N/A
- Fundamental
- Price
- WHWK $1.94
- IGI $16.41
- Analyst Decision
- WHWK
- IGI
- Analyst Count
- WHWK 0
- IGI 0
- Target Price
- WHWK N/A
- IGI N/A
- AVG Volume (30 Days)
- WHWK 148.4K
- IGI 33.9K
- Earning Date
- WHWK 08-15-2025
- IGI 01-01-0001
- Dividend Yield
- WHWK N/A
- IGI 4.79%
- EPS Growth
- WHWK N/A
- IGI N/A
- EPS
- WHWK 0.91
- IGI N/A
- Revenue
- WHWK $27,775,000.00
- IGI N/A
- Revenue This Year
- WHWK $49.83
- IGI N/A
- Revenue Next Year
- WHWK N/A
- IGI N/A
- P/E Ratio
- WHWK $2.24
- IGI N/A
- Revenue Growth
- WHWK 16.51
- IGI N/A
- 52 Week Low
- WHWK $1.21
- IGI $15.13
- 52 Week High
- WHWK $3.81
- IGI $17.79
- Technical
- Relative Strength Index (RSI)
- WHWK N/A
- IGI 46.82
- Support Level
- WHWK N/A
- IGI $16.36
- Resistance Level
- WHWK N/A
- IGI $16.53
- Average True Range (ATR)
- WHWK 0.00
- IGI 0.17
- MACD
- WHWK 0.00
- IGI -0.02
- Stochastic Oscillator
- WHWK 0.00
- IGI 33.33
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.
Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.